CSL Behring

BERINERT

Manufacturer:

CSL Behring

Berinert HCPCS:

J0597

HCPCS Code Descriptor:

Injection, c-1 esterase inhibitor (human), berinert, 10 units

Category:

J Code

Berinert NDCs:

63833-0825-02

Primary Type:

Immunology

Generic/Specialty Status:

Single-Source

Package Type:

Kit

Route of Administration:

Intravenous

Berinert CPT Codes:

Potential CPT administration codes for Berinert can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Berinert:

BERINERT is an Immunology drug manufactured by CSL Behring and administered via the Intravenous route of administration. The J Code: J0597 is aligned to the drug BERINERT.

ACCESS PRICING AND MORE BY REGISTERING

J0597 Added Date:

January 1, 2011

J0597 Effective Date:

January 1, 2011

J0597 Termination Date:

HCPCS Active

Berinert billing and coding information can be found through Csl Behring at the link below:
Berinert patient assistance information can be found through Berinert Connect at the URL: https://www.berinert.com/
BERINERT prescribing information can be found at the link below:
Information regarding BERINERT’s side effects can be found at MedlinePlus